Ameren financials
$100.25+0.87%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.09B | $2.18B | $1.78B | $2.70B | $2.22B | $2.10B | $1.94B | $2.17B | $1.69B | $1.82B | $1.62B | $2.06B |
| Gross profit | $1.55B | $1.57B | $1.43B | $1.91B | $1.39B | $1.43B | $1.31B | $1.64B | $1.33B | $1.34B | $1.25B | $1.60B |
| Gross margin | 73.9% | 72.2% | 80.0% | 70.6% | 62.5% | 68.0% | 67.4% | 75.7% | 78.7% | 73.6% | 77.2% | 77.7% |
| Operating income | $459.0M | $532.0M | $360.0M | $825.0M | $411.0M | $430.0M | $198.0M | $586.0M | $361.0M | $371.0M | $264.0M | $614.0M |
| Net income | $314.0M | $357.0M | $252.0M | $640.0M | $275.0M | $289.0M | $207.0M | $456.0M | $258.0M | $261.0M | $158.0M | $493.0M |
| Net margin | 15.0% | 16.4% | 14.1% | 23.7% | 12.4% | 13.8% | 10.7% | 21.0% | 15.2% | 14.4% | 9.8% | 23.9% |
| Diluted EPS | $1.13 | $1.28 | $0.92 | $2.35 | $1.01 | $1.07 | $0.77 | $1.70 | $0.97 | $0.98 | $0.60 | $1.87 |
| EBITDA | $905.0M | $970.0M | $790.0M | $1.25B | $809.0M | $845.0M | $602.0M | $989.0M | $762.0M | $768.0M | $264.0M | $994.0M |
| Operating cash flow | $770.0M | $421.0M | $956.0M | $1.10B | $862.0M | $431.0M | $817.0M | $897.0M | $557.0M | $492.0M | $689.0M | $845.0M |
| Free cash flow | -$310.0M | -$1.18B | -$80.0M | $115.0M | -$205.0M | -$651.0M | -$507.0M | -$260.0M | -$470.0M | -$410.0M | -$448.0M | $83.0M |
| Diluted shares | 278.7M | 278.4M | 273.6M | 272.2M | 271.6M | 271.4M | 268.7M | 267.3M | 266.8M | 266.8M | 263.9M | 263.4M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $12.0M | $13.0M | $13.0M | $9.0M | $11.0M | $23.0M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $22.05B | $21.48B | $20.06B | $20.29B | $20.21B | $19.78B |
| Total assets | $51.22B | $49.85B | $48.48B | $47.42B | $46.63B | $45.66B |
| Total liabilities | $37.40B | $36.16B | $34.95B | $34.51B | $34.18B | $33.32B |
| Shareholders' equity | $13.82B | $13.69B | $13.53B | $12.91B | $12.44B | $12.35B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology